Ligand · MRY
MRY · Meso-erythritol
MRY, Meso-erythritol (C4 H10 O4, 122.1 g/mol), in the MolNFT structures on GenesisL1: bound in 21 records (14 PDB entries). Every binding site with its residues within 4.5 Å, the residues it binds most and the ligands found with it.
- Component
- MRY
- Formula
- C4 H10 O4
- Class
- ligand
- Structures
- 21
- PDB entries
- 14
Binding sites
MRY in 21 structures; the first of them:
- 1T7L · Crystal Structure of Cobalamin-Independent Methionine Synthase from T. maritima · MRY A1353 · binds LYS104, PHE105, PHE106, TYR112, TYR155, LEU156, ARG165, CYS205 and 2 more
- 1XDJ · Crystal Structure of T. maritima Cobalamin-Independent Methionine Synthase complexed with… · MRY A1053 · binds LYS104, PHE105, PHE106, TYR112, TYR155, LEU156, ARG165, CYS205 and 1 more
- 1XPG · Crystal Structure of T. maritima Cobalamin-Independent Methionine Synthase complexed with… · MRY A1890 · binds LYS104, PHE105, PHE106, TYR112, LEU156, ARG165, CYS205, ILE587
- 1XR2 · Crystal Structure of oxidized T. maritima Cobalamin-Independent Methionine Synthase… · MRY A1205 · binds LYS104, PHE105, PHE106, TYR112, TYR155, LEU156, ARG165, CYS205 and 1 more
- 5EUK · Cetuximab Fab in complex with F3H meditope variant · MRY C301 · binds GLN155, SER156, GLY157, ASN158, SER159
- 5HHF · Crystal structure of Aspergillus fumigatus UDP-Galactopyranose mutase mutant H63A with… · MRY A602 · binds GLN438, TRP443, ARG445, ASN471, GLU478, LEU481, ASN482, GLU494
- 5T1K · Cetuximab Fab in complex with CQFDA(Ph)2STRRLKC · MRY C301 · binds LEU154, GLN155, SER156, GLY157, SER159
- 5U3D · Structure of meditope enabled trastuzumab I83E variant · MRY A301 · binds GLN37, ARG39, ARG45, ARG61, PHE62, GLU81, ASP82
- 5U5F · MEDITOPE ENABLED TRASTUZUMAB I83E VARIANT IN COMPLEX WITH (Ac) CQFDA(PH)2STRRLRCGGSK · MRY B301 · binds TYR152, GLU155, PRO156, VAL157, THR158, ALA175, LEU185, 2GX5 and 1 more
- 5U5M · Crystal structure of I83E meditope-enabled trastuzumab with azido-meditope · MRY B301 · binds GLU155, PRO156, VAL157, ALA175, LEU185, 2GX5, SER6
- 5U6A · Crystal structure of I83E meditope-enabled trastuzumab with azido-PEG3-meditope · MRY B301 · binds TYR152, GLU155, PRO156, VAL157, ALA175, LEU185, 2GX5, SER6
- 6UGV · Crystal structure of the Fab fragment of anti-TNFa antibody infliximab (Remicade) in a… · MRY H301 · binds GLY141, THR142, THR190, VAL191, PRO192
- 7C64 · Crystal structure of beta-glycosides-binding protein of ABC transporter in an open state… · MRY A511 · binds ARG354, THR355, GLN358
- 8U2M · Structure of P450Blt from Micromonospora sp. MW-13 in Complex with Biarylitide · MRY B403 · binds PRO106, LEU107, SER108, SER100, ALA101, GLU104, ALA210, ARG213 and 2 more
- 5T1K · Cetuximab Fab in complex with CQFDA(PH)2STRRLKC · MRY C301 · binds GLN155, SER156, GLY157
- 5U3D · Structure of meditope enabled trastuzumab I83E variant · MRY A301 · binds GLN37, ARG39, ARG45, ARG61, PHE62, GLU81, ASP82
- 5U5F · Meditope enabled trastuzumab I83E variant in complex with (ac) CQFDA(PH)2STRRLRCGGSK · MRY B301 · binds TYR152, GLU155, PRO156, VAL157, ALA175, LEU185, 2GX5, SER6
- 5U5M · Crystal structure of I83E meditope-enabled trastuzumab with azido- meditope · MRY B301 · binds GLU155, PRO156, VAL157, ALA175, LEU185, 2GX5, SER6
- 5U6A · Crystal structure of I83E meditope-enabled trastuzumab with azido- PEG3-meditope · MRY B301 · binds GLU155, PRO156, VAL157, ALA175, LEU185, 2GX5, SER6
- 6UGV · Crystal structure of the Fab fragment of anti-tnfa antibody infliximab (remicade) in a… · MRY H301 · binds GLY141, THR142, THR190, PRO192
- 7C64 · Crystal structure of beta-glycosides-binding protein of ABC transporter in an open state… · MRY A511 · binds ARG354, THR355, GLN358
Residues it binds most
ARG 19, LEU 20, PHE 10, TYR 11, GLU 13, GLN 13, SER 10, THR 9, PRO 11, ALA 7 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.